Medtronic declares a cash dividend for the second quarter of its fiscal year 2026.
Medtronic plc, the leading global healthcare technology company, has announced a cash dividend for the second quarter of its fiscal year 2026. This decision marks a continuation of the company's commitment to shareholder returns.
The cash dividend, amounting to $0.71 per ordinary share, is consistent with the dividend increase announcement made by Medtronic in May 2025. This dividend is expected to provide a steady income stream for shareholders, further bolstering their investments.
Medtronic, headquartered in Galway, Ireland, has a solid history of raising dividends. In fact, the company has increased its annual dividend payment for the past 48 consecutive years, a testament to its financial stability and commitment to shareholders.
The dividend payable on October 17, 2025, to shareholders of record at the close of business on September 26, 2025, is part of this ongoing commitment. The dividend yield, which currently stands around 3.08% to 3.20%, offers an attractive return for investors.
The company's products span a wide range of healthcare technologies, treating 70 different health conditions. From cardiac devices to surgical robotics, insulin pumps, surgical tools, and patient monitoring systems, Medtronic's offerings are diverse and extensive.
For further information regarding this cash dividend, investors are encouraged to contact Medtronic's Investor Relations department. Ryan Weispfenning, the Investor Relations contact at Medtronic, can be reached at 1-763-505-4626.
The original content and multimedia for this news can be viewed and downloaded at this link.
[1] Medtronic plc Dividend History (2016-2025) [2] Medtronic plc Dividend Dates and History (as of mid-2025) [3] Medtronic plc's Dividend Yield and Payout Ratio (as of mid-2025) [4] Medtronic plc's Next Ex-Dividend Date and Payment Date (as of mid-2025)
The announcement of Medtronic plc's cash dividend for the second quarter of its fiscal year 2026 indicates a continued emphasis on business finance and shareholder returns.This dividend, amounting to $0.71 per ordinary share, aligns with the dividend increase announcement made by Medtronic in May 2025, serving as a reliable income source for shareholders and reinforcing their investments.
